The efficacy and safety of transurethral enucleation of the prostate for benign prostatic hyperplasia using King health questionnaire assessment

The efficacy and safety of transurethral enucleation of the prostate for benign prostatic hyperplasia using King health questionnaire assessment - The efficacy and safety of HoLEP using King health questionnaire assessment

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000041240

Enrollment

100

Registered

2020-07-29

Start date

2017-07-21

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

benign prostatic hyperplasia

Interventions

None listed

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: 1)Estimated prostate volume is 30 ml or more 2)Patients who will undergo Holmium laser enucleation of the prostate at our hospital

Exclusion criteria

Exclusion criteria: 1)Patients who have severe incontinence before surgery due to severe cerebrovascular disorder or spinal cord injury

Design outcomes

Primary

Measure	Time frame
Quality of life assessment using the King Health Study at 1, 3 and 6 months post-operatively	—

Countries

Japan

Contacts

Public ContactGo Anan

Tohoku Medical and Pharmaceutical University Hospital Department of Urology

goanan@tohoku-mpu.ac.jp022-234-4181

Outcome results